The Cancer Drug Development Forum organized a live webinar regarding Treatment of Cancer Patients during the SARS-CoV2 Pandemic: Implications for Clinical Trials on Thursday 2 April 2020 at 18:30 (CET). This online conference was composed of a 25-minute lecture given by Prof. Dr. Marie von Lilienfeld-Toal followed by a 30-minute discussion session.
Prof. Marie von Lilienfeld-Toal is Professor of Medicine at the University Clinic of Jena Germany. Her clinical and scientific focus on haematological malignancies and Infectious Diseases in immunocompromised patients with a focus on virology. She is also the author of the
- 18:30 – 18:35 (CET): Introduction (Prof. Axel Glasmacher, CDDF)
- 18:35 – 19:00 (CET): Lecture (Prof. Marie von Lilienfeld-Toal)
- 19:00 – 19:30 (CET): Discussion (moderated by Prof. Axel Glasmacher and Prof. Jaap Verweij, CDDF)
View speaker’s presentation slides